Aytu Biopharma earnings were -$5.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest AYTU earnings report on Dec 31, 2024 announced Q4 2024 earnings of $788.0k, down 46.5% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, AYTU reported annual earnings of -$15.8M, with -7.1% growth. The next AYTU earnings date is May 13, 2025.
On AYTU's earnings call on Invalid Date, Aytu Biopharma (NASDAQ: AYTU) reported Q4 2024 earnings per share (EPS) of $0.13, up 425% year over year. Total AYTU earnings for the quarter were $788.00 thousand. In the same quarter last year, Aytu Biopharma's earnings per share (EPS) was -$0.04.
The next AYTU earnings date is Invalid Date. Add AYTU to your watchlist to be reminded of Aytu Biopharma's next earnings date.
Is Aytu Biopharma profitable or losing money?
As of the last Aytu Biopharma earnings report, Aytu Biopharma is currently losing money. Aytu Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$5.24 million, a 70.87% decrease year over year.
What was AYTU's earnings growth in the past year?
As of Aytu Biopharma's earnings date in Invalid Date, Aytu Biopharma's earnings has grown year over year. AYTU earnings in the past year totalled -$5.24 million.
What are Aytu Biopharma's earnings expectations?
The current EPS estimate for Aytu Biopharma's earnings report in Invalid Date is -$0.64.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.